{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:52:23Z","timestamp":1772059943847,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T00:00:00Z","timestamp":1268697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s11926-010-0086-1","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T04:05:18Z","timestamp":1268625918000},"page":"101-107","source":"Crossref","is-referenced-by-count":38,"title":["Hyperimmunoglobulin D Syndrome in Childhood"],"prefix":"10.1007","volume":"12","author":[{"given":"Jeroen C. H.","family":"van der Hilst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,16]]},"reference":[{"key":"86_CR1","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","volume":"345","author":"JPH Drenth","year":"2001","unstructured":"Drenth JPH, van der Meer JWM: Hereditary periodic fever. N Engl J Med 2001, 345:1748\u20131757.","journal-title":"N Engl J Med"},{"key":"86_CR2","doi-asserted-by":"crossref","unstructured":"van der Hilst JC, van der Meer JW, Drenth JP: Autoinflammatory fever syndromes. In Clinical Immunology: Principles and Practice, edn 3. Edited by Rich RR. St Louis, MO: Mosby; 2008.","DOI":"10.1016\/B978-0-323-04404-2.10060-0"},{"key":"86_CR3","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ, et al.: An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009, 360:2426\u20132437.","journal-title":"N Engl J Med"},{"key":"86_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Masters SL, Simon A, Aksentijevich I, Kastner DL: Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009, 27:621\u2013668. This excellent review on the pathogenesis of the autoinflammatory diseases focuses on the molecular pathways that lead to inflammation.","DOI":"10.1146\/annurev.immunol.25.022106.141627"},{"key":"86_CR5","first-page":"178","volume":"22","author":"JP Drenth","year":"1999","unstructured":"Drenth JP, Cuisset L, Grateau G, et al.: Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999, 22:178\u2013181.","journal-title":"International Hyper-IgD Study Group. Nat Genet"},{"key":"86_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","volume":"22","author":"SM Houten","year":"1999","unstructured":"Houten SM, Kuis W, Duran M, et al.: Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 1999, 22:175\u2013177.","journal-title":"Nat Genet"},{"key":"86_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"A Simon","year":"2004","unstructured":"Simon A, Drewe E, van der Meer JW, et al.: Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 2004, 75:476\u2013478.","journal-title":"Clin Pharmacol Ther"},{"key":"86_CR8","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mandey","year":"2006","unstructured":"Mandey SH, Kuijk LM, Frenkel J, Waterham HR: A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 2006, 54:3690\u20133695.","journal-title":"Arthritis Rheum"},{"key":"86_CR9","doi-asserted-by":"crossref","unstructured":"\u2022 Kuijk LM, Mandey SH, Schellens I, et al.: Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol 2008, 45:2158\u20132165. This elegant in vitro study further elucidated the importance of isoprenoids in the activation of caspase-1 and interleukin-1\u03b2 secretion.","DOI":"10.1016\/j.molimm.2007.12.008"},{"key":"86_CR10","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","volume":"112","author":"LM Kuijk","year":"2008","unstructured":"Kuijk LM, Beekman JM, Koster J, et al.: HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3K\/PKB-dependent caspase-1 activation. Blood 2008, 112:3563\u20133573.","journal-title":"Blood"},{"key":"86_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/ecn.2009.0163","volume":"20","author":"S Normand","year":"2009","unstructured":"Normand S, Massonnet B, Delwail A, et al.: Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Eur Cytokine Netw 2009, 20:101\u2013107.","journal-title":"Eur Cytokine Netw"},{"key":"86_CR12","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2005-10-039578","volume":"109","author":"EJ Bodar","year":"2007","unstructured":"Bodar EJ, van der Hilst JC, van Heerde W, et al.: Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome. Blood 2007, 109:2416\u20132418.","journal-title":"Blood"},{"key":"86_CR13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(84)92505-4","volume":"1","author":"JWM Meer van der","year":"1984","unstructured":"van der Meer JWM, Vossen JM, Radl J, et al.: Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1984, 1:1087\u20131090.","journal-title":"Lancet"},{"key":"86_CR14","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 van der Hilst JC, Bodar EJ, Barron KS, et al.: Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 2008, 87:301\u2013310. The largest study of HIDS patients so far described the clinical characteristics and follow-up of 103 patients. It also showed that HIDS significantly impairs the quality of life.","DOI":"10.1097\/MD.0b013e318190cfb7"},{"key":"86_CR15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3899\/jrheum.081313","volume":"36","author":"O Steichen","year":"2009","unstructured":"Steichen O, van der Hilst J, Simon A, et al.: A clinical criterion to exclude the hyperimmunoglobulin D syndrome (mild mevalonate kinase deficiency) in patients with recurrent fever. J Rheumatol 2009, 36:1677\u20131681.","journal-title":"J Rheumatol"},{"key":"86_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","volume":"73","author":"JP Drenth","year":"1994","unstructured":"Drenth JP, Haagsma CJ, van der Meer JW: Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994, 73:133\u2013144.","journal-title":"Medicine (Baltimore)"},{"key":"86_CR17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.2006.068841","volume":"66","author":"I Kone-Paut","year":"2007","unstructured":"Kone-Paut I, Sanchez E, Le QA, et al.: Autoinflammatory gene mutations in Behcet\u2019s disease. Ann Rheum Dis 2007, 66:832\u2013834.","journal-title":"Ann Rheum Dis"},{"key":"86_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-7-14","volume":"7","author":"CL Kraus","year":"2009","unstructured":"Kraus CL, Culican SM: Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatr Rheumatol Online J 2009, 7:14.","journal-title":"Pediatr Rheumatol Online J"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","volume":"5","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Simon A, Drenth JP: Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005, 5:87\u201398.","journal-title":"Clin Exp Med"},{"key":"86_CR20","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM200311063491920","volume":"349","author":"JC Hilst van der","year":"2003","unstructured":"van der Hilst JC, Simon A, Drenth JP: Molecular mechanisms of amyloidosis. N Engl J Med 2003, 349:1872\u20131873.","journal-title":"N Engl J Med"},{"key":"86_CR21","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","volume":"50","author":"L Obici","year":"2004","unstructured":"Obici L, Manno C, Muda AO, et al.: First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 2004, 50:2966\u20132969.","journal-title":"Arthritis Rheum"},{"key":"86_CR22","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.21901","volume":"54","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, Goodman HJ, Andrews PA, et al.: AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum 2006, 54:2010\u20132014.","journal-title":"Arthritis Rheum"},{"key":"86_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13506120500106982","volume":"12","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Drenth JP, Bodar EJ, et al.: Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 2005, 12:115\u2013119.","journal-title":"Amyloid"},{"key":"86_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1388-1981(00)00135-9","volume":"1529","author":"SM Houten","year":"2000","unstructured":"Houten SM, Wanders RJ, Waterham HR: Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta 2000, 1529:19\u201332.","journal-title":"Biochim Biophys Acta"},{"key":"86_CR25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","volume":"9","author":"L Cuisset","year":"2001","unstructured":"Cuisset L, Drenth JP, Simon A, et al.: Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 2001, 9:260\u2013266.","journal-title":"Eur J Hum Genet"},{"key":"86_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/rheumatology\/kei138","volume":"45","author":"A Simon","year":"2006","unstructured":"Simon A, van der Meer JW, Vesely R, et al.: Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) 2006, 45:269\u2013273.","journal-title":"Rheumatology (Oxford)"},{"key":"86_CR27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/ard.2006.054304","volume":"65","author":"L Federici","year":"2006","unstructured":"Federici L, Rittore-Domingo C, Kone-Paut I, et al.: A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 2006, 65:1427\u20131432.","journal-title":"Ann Rheum Dis"},{"key":"86_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1010525206818","volume":"24","author":"M Rocco Di","year":"2001","unstructured":"Di Rocco M, Caruso U, Waterham HR, et al.: Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D. J Inherit Metab Dis 2001, 24:411\u2013412.","journal-title":"J Inherit Metab Dis"},{"key":"86_CR29","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","volume":"46","author":"C Dode","year":"2002","unstructured":"Dode C, Andre M, Bienvenu T, et al.: The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002, 46:2181\u20132188.","journal-title":"Arthritis Rheum"},{"key":"86_CR30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.ejhg.5200725","volume":"9","author":"M Medlej-Hashim","year":"2001","unstructured":"Medlej-Hashim M, Petit I, Adib S, et al.: Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations. Eur J Hum Genet 2001, 9:849\u2013854.","journal-title":"Eur J Hum Genet"},{"key":"86_CR31","doi-asserted-by":"crossref","unstructured":"\u2022 Ammouri W, Cuisset L, Rouaghe S, et al.: Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 2007, 46:1597\u2013600. This study showed that serum IgD values do not predict which patients with a clinical suspicion of HIDS actually have mutations in MVK.","DOI":"10.1093\/rheumatology\/kem200"},{"key":"86_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1545-5300.1992.00383.x","volume":"31","author":"DS Rait","year":"1992","unstructured":"Rait DS, Ostroff JS, Smith K, et al.: Lives in a balance: perceived family functioning and the psychosocial adjustment of adolescent cancer survivors. Fam Process 1992, 31:383\u2013397.","journal-title":"Fam Process"},{"key":"86_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pon.839","volume":"14","author":"H Stam","year":"2005","unstructured":"Stam H, Grootenhuis MA, Last BF: The course of life of survivors of childhood cancer. Psychooncology 2005, 14:227\u2013238.","journal-title":"Psychooncology"},{"key":"86_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jadohealth.2005.03.011","volume":"39","author":"H Stam","year":"2006","unstructured":"Stam H, Hartman EE, Deurloo JA, et al.: Young adult patients with a history of pediatric disease: impact on course of life and transition into adulthood. J Adolesc Health 2006, 39:4\u201313.","journal-title":"J Adolesc Health"},{"key":"86_CR35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-3565(24)29496-9","volume":"298","author":"JP Drenth","year":"2001","unstructured":"Drenth JP, Vonk AG, Simon A, et al.: Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 2001, 298:1221\u20131226.","journal-title":"J Pharmacol Exp Ther"},{"key":"86_CR36","first-page":"24","volume":"63","author":"EJ Bodar","year":"2005","unstructured":"Bodar EJ, van der Hilst JC, Drenth JP, et al.: Effect of etanercept and anakinra on inflammatory attacks in the Hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 2005, 63:24\u201328.","journal-title":"Neth J Med"},{"key":"86_CR37","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"K Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V, et al.: Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2003, 48:2645\u20132651.","journal-title":"Arthritis Rheum"},{"key":"86_CR38","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1542\/peds.2006-2015","volume":"119","author":"M Nevyjel","year":"2007","unstructured":"Nevyjel M, Pontillo A, Calligaris L, et al.: Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics 2007, 119:e523\u2013e527.","journal-title":"Pediatrics"},{"key":"86_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","volume":"27","author":"D Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Bertoni B, et al.: Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome. Rheumatol Int 2006, 27:97\u2013100.","journal-title":"Rheumatol Int"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-010-0086-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0086-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:54:30Z","timestamp":1739969670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-010-0086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,16]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s11926-010-0086-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,16]]}}}